Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP Radio Conjugates
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
Webinars
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Sustainability (ESG)
News & Events
2021
,
Investors
,
Press Releases
Il Consiglio di Amministrazione Approva la Relazione Finanziaria Semestrale al 30 giugno 2021 (Price sensitive)
Sep 28, 2021
20210928 Philogen Comunicato stampa_semestrale 2021
Last News & Events
Sep
2023
20
Fighting Cancer, the Italian Chemical Society Award to Dario Neri, CEO of Philogen
Sep
2023
18
18 settembre 2023 – Aggiornamento sul programma di acquisto di azioni proprie
1
2
3
…
103
Next »